Table 1. Clinical Characteristics of AML Patients.
| Characteristics | AML (n = 545) | |
| No. | (%) | |
| Lineage | ||
| Myeloid | 378 | 69.4 |
| Myeloid and Lymphoid | 157 | 28.8 |
| Myeloid and Monocytic | 10 | 1.8 |
| Classification of diagnosis | ||
| M0 | 3 | 0.6 |
| M1 | 103 | 18.9 |
| M2 | 175 | 32.1 |
| M3 | 90 | 16.5 |
| M4 | 58 | 10.6 |
| M5 | 89 | 16.3 |
| Unknown | 27 | 5.0 |
| Karyotype | ||
| Aberrant | 246 | 45.1 |
| t(9;22) | 11 | 2.0 |
| t(8;21) | 48 | 8.8 |
| t(15;17) | 64 | 11.7 |
| complex | 114 | 20.9 |
| others | 9 | 1.7 |
| Normal | 235 | 43.1 |
| Unknown | 64 | 11.8 |
| Molecular subtype | ||
| Common fusion gene transcripts | 187 | 34.3 |
| PML/RARα | 77 | 14.1 |
| BCR/ABL | 13 | 2.4 |
| AML1/ETO | 54 | 9.9 |
| CBFβ/MYH11 | 10 | 1.8 |
| MLL rearrangement | 15 | 2.8 |
| WT1 | 11 | 2.0 |
| Others | 7 | 1.3 |
| No common fusion gene ranscripts | 303 | 55.6 |
| Unknown | 55 | 10.1 |